Targeted inhibition of IL-18 attenuates irinotecan-induced intestinal mucositis in mice (2014)
Fonte: British Journal of Pharmacology. Unidade: FMRP
Assuntos: PEPTÍDEOS, PROTEÍNAS, INTERLEUCINAS (ANTAGONISTAS E INIBIDORES), MUCOSA INTESTINAL (EFEITOS DE DROGAS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA-JÚNIOR, R. C. P et al. Targeted inhibition of IL-18 attenuates irinotecan-induced intestinal mucositis in mice. British Journal of Pharmacology, v. 171, n. 9, p. 2335-2350, 2014Tradução . . Disponível em: https://doi.org/10.1111/bph.12584. Acesso em: 03 nov. 2024.APA
Lima-Júnior, R. C. P., Freitas, H. C., Wong, D. V. T., Wanderley, C. W. S., Nunes, L. G., Leite, L. L., et al. (2014). Targeted inhibition of IL-18 attenuates irinotecan-induced intestinal mucositis in mice. British Journal of Pharmacology, 171( 9), 2335-2350. doi:10.1111/bph.12584NLM
Lima-Júnior RCP, Freitas HC, Wong DVT, Wanderley CWS, Nunes LG, Leite LL, Miranda SP, Souza MHLP, Brito GAC, Magalhães PJC, Teixeira MM, Cunha F de Q, Ribeiro RA. Targeted inhibition of IL-18 attenuates irinotecan-induced intestinal mucositis in mice [Internet]. British Journal of Pharmacology. 2014 ; 171( 9): 2335-2350.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1111/bph.12584Vancouver
Lima-Júnior RCP, Freitas HC, Wong DVT, Wanderley CWS, Nunes LG, Leite LL, Miranda SP, Souza MHLP, Brito GAC, Magalhães PJC, Teixeira MM, Cunha F de Q, Ribeiro RA. Targeted inhibition of IL-18 attenuates irinotecan-induced intestinal mucositis in mice [Internet]. British Journal of Pharmacology. 2014 ; 171( 9): 2335-2350.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1111/bph.12584
